Ariad Pharmaceuticals Inc fka ARIA

[BTH]

Question about Pivatol '534 trial

Ariad has the finances to "probably" scrape through what they have in cash ~$80 million, to finance a final '534 trial.

What are your thoughts (Don) on a partnership and when such partnership, if and when, would take place.

Personally, I think that a '534 end-stage trial should have input (and backing) from a large pharma. It is just easier for Ariad being a small, underfunded and undercapitalized firm. Also, you get incredible knowledge from large pharma who has already done hundreds of these FDA trials. Ariad, has only done a handful, and only ONE P3 trial.

A partnership also gives them leverage to expand into solid tumors quickly and AML. Ariad does not have the cash to push all these, and '113 into trials alone.

Thoughts?